|
1
|
Shen X, Wang L and Zhu L: Spatial analysis
of regional factors and lung cancer mortality in China, 1973–2013.
Cancer Epidemiol Biomarkers Prev. 26:569–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fujita Y, Kosaka N, Araya J, Kuwano K and
Ochiya T: Extracellular vesicles in lung microenvironment and
pathogenesis. Trends Mol Med. 21:533–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Théry C, Ostrowski M and Segura E:
Membrane vesicles as conveyors of immune responses. Nat Rev
Immunol. 9:581–593. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cocucci E, Racchetti G and Meldolesi J:
Shedding microvesicles: Artefacts no more. Trends Cell Biol.
19:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Simons M and Raposo G: Exosomes-vesicular
carriers for intercellular communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jaiswal R, Gong J, Sambasivam S, Combes V,
Mathys JM, Davey R, Grau GE and Bebawy M: Microparticle-associated
nucleic acids mediate trait dominance in cancer. FASEB J.
26:420–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanfiorenzo C, Ilie MI, Belaid A, Barlési
F, Mouroux J, Marquette CH, Brest P and Hofman P: Two panels of
plasma microRNAs as non-invasive biomarkers for prediction of
recurrence in resectable NSCLC. PLoS One. 8:e545962013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Foss KM, Sima C, Ugolini D, Neri M, Allen
KE and Weiss GJ: miR-1254 and miR-574-5p: Serum-based microRNA
biomarkers for early-stage non-small cell lung cancer. J Thorac
Oncol. 6:482–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Yang D, Zhang H, Wei X, Ma T,
Cheng Z, Hong Q, Hu J, Zhuo H, Song Y, et al: Early detection of
lung cancer in serum by a panel of MicroRNA biomarkers. Clin Lung
Cancer. 16:313–319.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bianchi F, Nicassio F, Marzi M, Belloni E,
Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G and Di
Fiore PP: A serum circulating miRNA diagnostic test to identify
asymptomatic high-risk individuals with early stage lung cancer.
EMBO Mol Med. 3:495–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C,
Wang C, Ren Z, Zhao Y, Wu S, et al: Identification of ten serum
microRNAs from a genome-wide serum microRNA expression profile as
novel noninvasive biomarkers for nonsmall cell lung cancer
diagnosis. Int J Cancer. 130:1620–1628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen J, Todd NW, Zhang H, Yu L, Lingxiao
X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, et al: Plasma
microRNAs as potential biomarkers for non-small-cell lung cancer.
Lab Invest. 91:579–587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ulivi P, Foschi G, Mengozzi M, Scarpi E,
Silvestrini R, Amadori D and Zoli W: Peripheral blood miR-328
expression as a potential biomarker for the early diagnosis of
NSCLC. Int J Mol Sci. 14:10332–10342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scagliotti G, Hanna N, Fossella F,
Sugarman K, Blatter J, Peterson P, Simms L and Shepherd FA: The
differential efficacy of pemetrexed according to NSCLC histology: A
review of two Phase III studies. Oncologist. 14:253–263. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuxia M, Zhennan T and Wei Z: Circulating
miR-125b is a novel biomarker for screening non-small-cell lung
cancer and predicts poor prognosis. J Cancer Res Clin Oncol.
138:2045–2050. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sozzi G, Boeri M, Rossi M, Verri C,
Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, et al:
Clinical utility of a plasma-based miRNA signature classifier
within computed tomography lung cancer screening: A correlative
MILD trial study. J Clin Oncol. 32:768–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang YL, Xu LP, Zhuo FL and Wang TY:
Prognostic value of microRNA-10b overexpression in peripheral blood
mononuclear cells of nonsmall-cell lung cancer patients. Tumour
Biol. 36:7069–7075. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H,
Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93 and miR-429
as potential biomarkers for detection of early stage non-small lung
cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H,
Liu X, Le H and Zhang Y: Diagnostic value of serum miR-182,
miR-183, miR-210, and miR-126 levels in patients with early-stage
non-small cell lung cancer. PLoS One. 11:e01530462016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou C, Chen Z, Dong J, Li J, Shi X, Sun
N, Luo M, Zhou F, Tan F and He J: Combination of serum miRNAs with
Cyfra21-1 for the diagnosis of non-small cell lung cancer. Cancer
Lett. 367:138–146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greither T, Grochola LF, Udelnow A,
Lautenschläger C, Würl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee KH, Lotterman C, Karikari C, Omura N,
Feldmann G, Habbe N, Goggins MG, Mendell JT and Maitra A:
Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent
kinase 6 expression in pancreatic cancer. Pancreatology. 9:293–301.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ahn SM, Cha JY, Kim J, Kim D, Trang HT,
Kim YM, Cho YH, Park D and Hong S: Smad3 regulates E-cadherin via
miRNA-200 pathway. Oncogene. 31:3051–3059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duan FT, Qian F, Fang K, Lin KY, Wang WT
and Chen YQ: miR-133b, a muscle-specific microRNA, is a novel
prognostic marker that participates in the progression of human
colorectal cancer via regulation of CXCR4 expression. Mol Cancer.
12:1642013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Diepenbruck M and Christofori G:
Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no,
maybe? Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Steinbichler TB, Dudás J, Riechelmann H
and Skvortsova II: The role of exosomes in cancer metastasis. Semin
Cancer Biol. 44:170–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F,
Bao G, Kong H, Ge C, Zhang F, et al: miRNA-200c inhibits invasion
and metastasis of human non-small cell lung cancer by directly
targeting ubiquitin specific peptidase 25. Mol Cancer. 13:1662014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng Z, Ma R, Tan W and Zhang L: MiR-152
suppresses the proliferation and invasion of NSCLC cells by
inhibiting FGF2. Exp Mol Med. 46:e1122014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, Fan
S, Cai H, Luo Q, Lv Z and Fan L: miR-194 inhibits the
proliferation, invasion, migration, and enhances the
chemosensitivity of non-small cell lung cancer cells by targeting
forkhead box A1 protein. Oncotarget. 7:13139–13152. 2016.PubMed/NCBI
|
|
36
|
Luo W, Huang B, Li Z, Li H, Sun L, Zhang
Q, Qiu X and Wang E: MicroRNA-449a is downregulated in non-small
cell lung cancer and inhibits migration and invasion by targeting
c-Met. PLoS One. 8:e647592013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wheeler DL, Dunn EF and Harari PM:
Understanding resistance to EGFR inhibitors-impact on future
treatment strategies. Nat Rev Clin Oncol. 7:493–507. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sangodkar J, Dhawan NS, Melville H, Singh
VJ, Yuan E, Rana H, Izadmehr S, Farrington C, Mazhar S, Katz S, et
al: Targeting the FOXO1/KLF6 axis regulates EGFR signaling and
treatment response. J Clin Invest. 122:2637–2651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen X, Zhu L, Ma Z, Sun G, Luo X, Li M,
Zhai S, Li P and Wang X: Oncogenic miR-9 is a target of erlotinib
in NSCLCs. Sci Rep. 5:170312015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li B, Ren S, Li X, Wang Y, Garfield D,
Zhou S, Chen X, Su C, Chen M, Kuang P, et al: MiR-21 overexpression
is associated with acquired resistance of EGFR-TKI in non-small
cell lung cancer. Lung Cancer. 83:146–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Babu KR and Muckenthaler MU: miR-20a
regulates expression of the iron exporter ferroportin in lung
cancer. J Mol Med (Berl). 94:347–359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Harel Adi S, Bossel Ben-Moshe N, Aylon Y,
Bublik DR, Moskovits N, Toperoff G, Azaiza D, Biagoni F, Fuchs G,
Wilder S, et al: Reactivation of epigenetically silenced miR-512
and miR-373 sensitizes lung cancer cells to cisplatin and restricts
tumor growth. Cell Death Differ. 22:1328–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao J, Fu W, Liao H, Dai L, Jiang Z, Pan
Y, Huang H, Mo Y, Li S, Yang G and Yin J: The regulatory and
predictive functions of miR-17 and miR-92 families on cisplatin
resistance of non-small cell lung cancer. BMC Cancer. 15:7312015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yamashita R, Sato M, Kakumu T, Hase T,
Yogo N, Maruyama E, Sekido Y, Kondo M and Hasegawa Y: Growth
inhibitory effects of miR-221 and miR-222 in non-small cell lung
cancer cells. Cancer Med. 4:551–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Garofalo M, Quintavalle C, Di Leva G,
Zanca C, Romano G, Taccioli C, Liu CG, Croce CM and Condorelli G:
MicroRNA signatures of TRAIL resistance in human non-small cell
lung cancer. Oncogene. 27:3845–3855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lv L, An X, Li H and Ma L: Effect of
miR-155 knockdown on the reversal of doxorubicin resistance in
human lung cancer A549/dox cells. Oncol Lett. 11:1161–1166. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jaiswal R, Gong J, Sambasivam S, Combes V,
Mathys JM, Davey R, Grau GE and Bebawy M: Microparticle-associated
nucleic acids mediate trait dominance in cancer. FASEB J.
26:420–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pigati L, Yaddanapudi SC, Iyengar R, Kim
DJ, Hearn SA, Danforth D, Hastings ML and Duelli DM: Selective
release of microRNA species from normal and malignant mammary
epithelial cells. PLoS One. 5:e135152010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rabinowits G, Gercel-Taylor C, Day JM,
Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker
for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cazzoli R, Buttitta F, Di Nicola M,
Malatesta S, Marchetti A, Rom WN and Pass HI: microRNAs derived
from circulating exosomes as noninvasive biomarkers for screening
and diagnosing lung cancer. J Thorac Oncol. 8:1156–1162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rodriguez M, Silva J, López-Alfonso A,
López-Muñiz MB, Peña C, Domínguez G, García JM, López-Gónzalez A,
Méndez M, Provencio M, et al: Different exosome cargo from
plasma/bronchoalveolar lavage in non-small-cell lung cancer. Genes
Chromosomes Cancer. 53:713–724. 2014.PubMed/NCBI
|
|
54
|
Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo R,
Cheng W, Wang F, Qi LW, Chen Y, et al: A six-microRNA panel in
plasma was identified as a potential biomarker for lung
adenocarcinoma diagnosis. Oncotarget. 8:6513–6525. 2017.PubMed/NCBI
|
|
55
|
Silva J, García V, Zaballos Á, Provencio
M, Lombardía L, Almonacid L, García JM, Domínguez G, Peña C, Diaz
R, et al: Vesicle-related microRNAs in plasma of nonsmall cell lung
cancer patients and correlation with survival. Eur Respir J.
37:617–623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Aushev VN, Zborovskaya IB, Laktionov KK,
Girard N, Cros MP, Herceg Z and Krutovskikh V: Comparisons of
microRNA patterns in plasma before and after tumor removal reveal
new biomarkers of lung squamous cell carcinoma. PLoS One.
8:e786492013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z,
Xiang Y, Wu N, Wu L, Bai L and Li Y: Circulating exosomal microRNAs
as prognostic biomarkers for non-small-cell lung cancer.
Oncotarget. 8:13048–13058. 2017.PubMed/NCBI
|
|
58
|
Barile L and Vassalli G: Exosomes: Therapy
delivery tools and biomarkers of diseases. Pharmacol Ther.
174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Cao M, Seike M, Soeno C, Mizutani H,
Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L and Gemma A:
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition
by targeting E-cadherin in lung cancer cells. Int J Oncol.
41:869–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kim J, Kim TY, Lee MS, Mun JY, Ihm C and
Kim SA: Exosome cargo reflects TGF-β1-mediated
epithelial-to-mesenchymal transition (EMT) status in A549 human
lung adenocarcinoma cells. Biochem Biophys Res Commun. 478:643–648.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Webber J, Steadman R, Mason MD, Tabi Z and
Clayton A: Cancer exosomes trigger fibroblast to myofibroblast
differentiation. Cancer Res. 70:9621–9630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li J, Yu J, Zhang H, Wang B, Guo H, Bai J,
Wang J, Dong Y, Zhao Y and Wang Y: Exosomes-derived MiR-302b
suppresses lung cancer cell proliferation and migration via TGFβRII
inhibition. Cell Physiol Biochem. 38:1715–1726. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
van den Boorn JG, Schlee M, Coch C and
Hartmann G: SiRNA delivery with exosome nanoparticles. Nat
Biotechnol. 29:325–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Xiao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu
Y and Feng J: Exosomes: Decreased sensitivity of lung cancer A549
cells to cisplatin. PLoS One. 9:e895342014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Jung JH, Lee MY, Choi DY, Lee JW, You S,
Lee KY, Kim J and Kim KP: Phospholipids of tumor extracellular
vesicles stratify gefitinib-resistant nonsmall cell lung cancer
cells from gefitinib-sensitive cells. Proteomics. 15:824–835. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Alvarez-Erviti L, Seow Y, Yin H, Betts C,
Lakhal S and Wood MJ: Delivery of siRNA to the mouse brain by
systemic injection of targeted exosomes. Nat Biotechnol.
29:341–345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Cooper JM, Wiklander PB, Nordin JZ,
Al-Shawi R, Wood MJ, Vithlani M, Schapira AH, Simons JP,
El-Andaloussi S and Alvarez-Erviti L: Systemic exosomal siRNA
delivery reduced alpha-synuclein aggregates in brains of transgenic
mice. Mov Disord. 29:1476–1485. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Morse MA, Garst J, Osada T, Khan S,
Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A,
et al: A phase I study of dexosome immunotherapy in patients with
advanced non-small cell lung cancer. J Transl Med. 3:92005.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Besse B, Charrier M, Lapierre V, Dansin E,
Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F,
Laplanche A, et al: Dendritic cell-derived exosomes as maintenance
immunotherapy after first line chemotherapy in NSCLC.
OncoImmunology. 5:e10710082015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pitt JM, André F, Amigorena S, Soria JC,
Eggermont A, Kroemer G and Zitvogel L: Dendritic cell-derived
exosomes for cancer therapy. J Clin Invest. 126:1224–1232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Marleau AM, Chen CS, Joyce JA and Tullis
RH: Exosome removal as a therapeutic adjuvant in cancer. J Transl
Med. 10:1342012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Chen D, Guo W, Qiu Z, Wang Q, Li Y, Liang
L, Liu L, Huang S, Zhao Y and He X: MicroRNA-30d-5p inhibits tumour
cell proliferation and motility by directly targeting CCNE2 in
non-small cell lung cancer. Cancer Lett. 362:208–217. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Rolfo C, Castiglia M, Hong D, Alessandro
R, Mertens I, Baggerman G, Zwaenepoel K, Gil-Bazo I, Passiglia F,
Carreca AP, et al: Liquid biopsies in lung cancer: The new ambrosia
of researchers. Biochim Biophys Acta. 1846:539–546. 2014.PubMed/NCBI
|
|
75
|
Xu W, Yang Z and Lu N: From pathogenesis
to clinical application: Insights into exosomes as transfer vectors
in cancer. J Exp Clin Cancer Res. 35:1562016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
György B, Hung ME, Breakefield XO and
Leonard JN: Therapeutic applications of extracellular vesicles:
Clinical promise and open questions. Annu Rev Pharmacol Toxicol.
55:439–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kourembanas S: Exosomes: Vehicles of
intercellular signaling, biomarkers, and vectors of cell therapy.
Annu Rev Physiol. 77:13–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
